Publication Date
1-1-2024
Journal
Antimicrobial Stewardship & Healthcare Epidemiology
DOI
10.1017/ash.2024.391
PMID
39563929
PMCID
PMC11574589
PubMedCentral® Posted Date
11-11-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Abstract
Although the initial specimen diversion device (ISDD) has been shown to reduce blood culture contamination (BCC) rates, its impact on clinical outcomes remains unclear. This multicenter study showed that ISDD significantly decreased BCC. However, there was no reduction in length of stay, days of therapy, or central line-associated bloodstream infections.